Results 221 to 230 of about 113,726 (260)

Hormone replacement therapy and the breast

Surgical Oncology, 2003
Increasing numbers of women are using hormone replacement therapy (HRT) in their 50s and 60s. Oestrogen alone or oestrogen and progestogen combined given in this age group increase breast density and this has the effect of reducing both the sensitivity and specificity of breast screening in HRT users.
openaire   +3 more sources

Aspects of Hormone Replacement Therapy

Annals of the New York Academy of Sciences, 1994
The most important benefit of ERT may well be its cardioprotective effect. But unopposed estrogen therapy also carries the risk of inducing endometrial cancer. A compelling body of evidence indicates that adjunctive progestogen protects effectively against estrogen-induced endometrial adenocarcinoma, and that progestogen therapy is effective in the ...
openaire   +2 more sources

Hormone replacement therapy in hypopituitarism

Expert Opinion on Pharmacotherapy, 2004
Hypopituitarism is a disease complex characterised by varying pituitary hormonal deficiencies. The causes and manifestations of hypopituitarism are diverse, the most common being the presence of or treatment of a pituitary adenoma. Pressure effects from the tumour itself on normal pituitary tissue, together with the effects of surgical resection ...
openaire   +2 more sources

Hormone replacement therapy and osteoporosis

Maturitas, 1996
Restoration of the osteoporotic skeleton is difficult. Factors that may aggravate the bone loss or increase the risk of fractures should be eliminated. The physician may then decide whether the patient is a candidate for one of the treatments which either stop further bone loss or increase the bone mass.
openaire   +2 more sources

Indications for Hormone Replacement Therapy

Therapeutische Umschau, 2000
Nach der Menopause kann es als Folge des Östrogenmangels einerseits zum klimakterischen Syndrom und andererseits zu Stoffwechselveränderungen mit möglichen Folgeerkrankungen kommen. Bei symptomatischen Östrogenmangelzuständen ist eine Hormonsubstitution aus therapeutischen Erwägungen indiziert.
openaire   +2 more sources

Compliance to hormone replacement therapy.

International journal of fertility and menopausal studies, 1995
info:eu-repo/semantics ...
Rozenberg, Serge, Vandromme, Jean, Kroll, Marie, Pastijn, Anne, Liebens, Fabienne   +4 more
openaire   +3 more sources

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Hope Rugo, Laura Huppert
exaly  

Hormone replacement therapy and fibroids

British Menopause Society Journal, 2002
Shrikant, Bollapragada, Rita, Panigrahy, Tony, Mander   +2 more
openaire   +2 more sources

Hormonal Replacement Therapy

Reviews in Endocrine and Metabolic Disorders, 2002
openaire   +2 more sources

Postmenopausal Hormone Replacement Therapy

Annals of Internal Medicine, 2003
Francine, Grodstein, JoAnn E, Manson, Meir J, Stampfer   +2 more
openaire   +2 more sources